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Myocardial Adrenergic Nervous Activity Is Intensified in Patients With 
Heart Failure Without Left Ventricular Volume or Pressure Overload 
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TAKAYA FUKUYAMA,  MD 
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Objectives. To clarify whether myocardial adrenergic activity is 
different in patients with heart failure without left ventricular 
volume or pressure overload, we used iodine-123 metaiodobenzyl- 
guanidine (MIBG) imaging to study patients with mitral stenosis. 
Background. In patients with heart failure due to cardiomyop- 
athy or to valve diseases with volume or pressure overload, or 
both, myocardial drenergic nerve activity is accelerated indepen- 
dent of underlying cause. However, it is not clear whether this 
change in myocardial adrenergic nerve activity is present in 
patients without left ventricular volume or pressure overload. 
Methods. The study patients were 20 men and women with 
normal eft ventricular function and heart failure due to mitral 
stenosis. Planar MIBG images obtained from these patients were 
compared with images from nine age-matched healthy subjects 
(control group). Myocardial uptake of MIBG was calculated as 
the heart/mediastinal activity ratio. Storage and release of MIBG 
were calculated as percent myocardial MIBG washout from 
15 min to 4 h after isotope injection. All 20 study patients 
underwent echocardiography, and 16 underwent right heart cath- 
eterization. 
Results. The heart/mediastinal activity ratio in the immediate 
images (15 min) did not show any significant difference between 
the patient and control groups. Myocardial washout was in- 
creased in patients with severe heart failure. The level of myocar- 
dial washout correlated with left atrial diameter (r = 0.51, p = 
0.02) and mitral valve area calculated with Doppler echocardiog- 
raphy (r = -0.61, p < 0.01) and mitral valve area calculated with 
cardiac catheterization (r = -0.62, p = 0.02). The closest 
correlation existed between myocardial washout and cardiac 
output (r = -0.80, p < 0.01). 
Conclusions. In heart failure due to mitral stenosis, myocardial 
adrenergic nerve activity is intensified. A decrease in cardiac 
output associated with mitral stenosis acts as a potent stimulus 
for this intensification. 
(J Am Coll Cardiol 1996;28:371-5) 
Metaiodobenzylguanidine (MIBG) is an analog of the adren- 
ergic blocking agent guanethidine and iodine-123 (I-123) 
MIBG has been used to study myocardial adrenergic nerve 
activity (1,2). In patients with cardiac diseases uch as dilated 
cardiomyopathy and valvular heart disease, abnormal findings 
in myocardial MIBG images have been observed (3-5). In 
patients with heart failure associated with cardiomyopathy and 
in patients associated with valve disease with volume or 
pressure overload, or both, the myocardial washout of MIBG 
is accelerated and its level is related to the severity of heart 
failure independent of the underlying cause (6). This abnormal 
finding has been implicated as intense myocardial adrenergic 
nervous stimulation in heart failure (7-13). 
Heart failure also develops in cases of mechanical abnor- 
mality without left ventricular pressure or volume overload, 
such as in mitral stenosis. In these cases, it has not yet been 
clarified whether myocardial adrenergic activity is different. In 
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the present investigation, we studied MIBG images from 20 
patients with heart failure due to mitral stenosis to elucidate 
the change of myocardial adrenergic nervous activity. 
Methods  
Study patients. Participants in this study were 20 patients 
with heart failure with rheumatic mitral stenosis. There were 8 
men and 12 women with a mean age +_ SD of 58 _+ 13 years. 
Three patients had sinus rhythm and 17 had atrial fibrillation. 
Eight patients were in New York Heart Association functional 
class I, six in class II and six in class III. To exclude the 
influence of right heart failure, patients with overt manifesta- 
tions of right heart failure or patients with significant ricuspid 
regurgitation by Doppler echocardiography were not included. 
Patients with a left ventricular ejection fraction <40%, as 
measured by routine radionuclide angiography, were omitted 
to exclude the influence of diminished myocardial function. 
Patients were taking a variety of medications at the time of the 
study, but none were taking tricyelic antidepressant or sympa- 
thomimetic agents or other drugs known to interfere with 
MIBG uptake. 
Control group. Nine normal subjects (four men and five 
women, mean age 58 _~ 3 years) who underwent clinical, 
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hematologic and biochemical screening, chest radiography, 
rest and exercise lectrocardiography, and echocardiography 
before admission to the study formed the control group. 
Protocol and imaging. Blood samples were drawn for 
plasma human atrial natriuretic peptide (hANP) and norepi- 
nephrine determinations after supine rest for a minimum of 1 h 
in the morning on the day of the MIBG imaging study. All 
medications, including digitalis preparations, diuretic drugs, 
beta-adrenergic blocking agents, angiotensin-converting en-
zyme inhibitors and calcium channel antagonists, were contin- 
ued. Potassium iodide, 2 mg orally, was given from 1 day 
before to 4 days after the study to block thyroid uptake of 1-123 
MIBG. The MIBG imaging was performed and analyzed as 
previously described (6). Briefly, patients were placed in the 
supine position and 111 MBq of 1-123 MIBG (Daiichi Radio- 
isotope Laboratory, Tokyo, Japan) was injected. Myocardial 
images were acquired by using a standard field gamma camera 
equipped with a low energy, parallel hole collimator (SNC- 
500R, Shimazu, Kyoto, Japan) and a 20% window centered at 
159 keV was used. Planar imaging was performed in the 
anterior view of the chest. The first acquisition began 15 rain 
after tracer injection (immediate image). Identical acquisition 
was obtained 4 h after injection (delayed image). 
Gated radionuclide angiography was performed by using a 
single-crystal scintillation camera (ZLC 3700, Siemens, Solna, 
Sweden) and the method of in vivo labeling of 99m 
technetium-RBC with 740 MBq of technetium-99m. 
Image analysis. Left ventricular 1-123 MIBG activity was 
measured by using a manually drawn region of interest around 
the left ventricular myocardium. A 20 x 20-pixel region of 
interest was placed over the upper mediastinal area. Back- 
ground subtraction was performed by using the upper medias- 
tinal region of interest. To evaluate myocardial uptake of 
MIBG, the heart/mediastinal (H/M) activity ratio was calcu- 
lated by the following formula from scintigrams obtained 
15 rain after isotope injection: 
H/M activity ratio = [H]/[M], 
where [H] = mean counts/pixel in the left ventricle; and [M] = 
mean counts/pixel in the upper mediastinum. Myocardial 
MIBG washout was defined as percent change in activity from 
the immediate and delayed images within the left ventricle as 
follows: 
{([H] - [M])immediat e - -  ([H] - [M])del,y~d}/([H] -- [M])immediate 
x 100 (%). 
Because systemic sympathetic activity is altered in patients 
with heart failure, accumulation and washout of MIBG in the 
liver, which does not have dense adrenergic innervation, were 
also measured and compared with those in the heart. A 20 x 
20 pixel region of interest was placed over the right lobe in the 
anterior view and analyzed in the same manner. 
Echocardiographic examination. All patients underwent 
two-dimensional nd Doppler echocardiography to determine 
left atrial diameter and mitral valve area. Left atrial diameter 
was measured in the parasternal long-axis view with two- 
Table 1. Echocardiographic and Hemodynamic Measurements of
Study Patients 
Mean + SD 
Measurement (normal value) 
Echocardiographic (n = 20) 
LAD (ram) 
MVA by Doppler study (em 2) 
Hemodynamic (n = 16) 
MRAP (ram Hg) 
MPAP (ram Hg) 
PEWP (ram Hg) 
MAoP (ram Hg) 
CI (liters/rain per m 2) 
MVA by Gorlin formula (cm 2) 
50.9 = 11.6(30 _+ 10') 
1.21 _+ 0.40 
6.0 -+ 3.0 (6 + 4#) 
22.2 + 6.3 (15 + 5?) 
16.3 ± 5.1 (9 +_ 4t) 
89.1 ± 14.5 (90 _+ 2or) 
2.39 ± 0.56 (3.8 _+ 1.3t) 
1.30 +_ 0.63 (4.7 _+ 0.2?) 
*,tNormal Japanese reference value cited from references 16" and 17t. Data 
presented are mean value -+ SD. CI = cardiac index; LAD = left atrial diameter; 
MAoP = mean aortic pressure; MPAP = mean pulmonary artery pressure; 
MRAP = mean right atrial pressure; MVA = mitral valve area; PCWP = mean 
pulmonary capillary wedge pressure. 
dimensional-guided M-mode echocardiography. Continuous 
wave Doppler ultrasound recordings were made from the 
apical four-chamber view and the Doppler mitral valve area 
was determined by the pressure half-time method (14). 
Hemodynamic measurements. Sixteen patients underwent 
right and left heart catheterization to determine right atrial 
pressure, pulmonary artery pressure, pulmonary capillary 
wedge pressure, left ventricular pressure, aortic pressure and 
cardiac output. Cardiac output was measured by the thermodi- 
lution method with a Swan-Ganz catheter, and cardiac index 
was calculated from standard formula. Mitral valve area was 
calculated according to the Gorlin formula with the use of 
mitral gradient and cardiac output (15). Echocardiographic 
and hemodynamic results are summarized in Table 1. 
Neuroendocrine measurement. Analysis of norepinephrine 
and hANP was performed as previously described (6). Briefly, 
norepinephrine analysis was performed with high performance 
liquid chromatography (HPLC) with electrochemical detec- 
tion. Plasma hANP was measured with a simplified radioim- 
munoassay using commercially available antibodies. 
Statistical analysis. Data are presented as mean value +_ 
SD. Comparison of more than two groups was performed by 
analysis of variance (ANOVA) followed by the multiple com- 
parison test (modified t test according to Bonferroni). Linear 
regression analysis was used to determine the correlations 
between the level of myocardial washout of MIBG and the 
neuroendocrine, chocardiographic and hemodynamic mea- 
surements. Stepwise multivariate regression analysis was used 
to determine the independent predictors of myocardial wash- 
out of MIBG. Differences were considered statistically signif- 
icant at p < 0.05. 
Resu l ts  
Plasma norepinephrine and hANP levels. Patients in func- 
tional classes II and III had higher plasma norepinephrine 
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Figure 1. Functional cardiac status (New York Heart Association 
[NYHA] classification) versus heart/mediastinal [H/M]) activity ratio 
in immediate images (top) and myocardial washout [MWO] of MIBG 
(bottom) in 20 patients. Data presented are mean value _+ SD. **p < 
0.0l versus control group (CONT); ~p < 0.01 versus functional class I; 
§p < 0.01 versus functional class II. 
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Figure 2. Relation between myocardial washout (MWO) and (top) 
mitral valve area calculated by the Gorlin formula and (bottom) 
cardiac index in 16 patients. Myocardial washout was inversely corre- 
lated with both mitral valve area (r = -0.62, p = 0.02) and cardiac 
index (r = -0.80, p < 0.01). 
and hANP levels (NS): norepinephrine: 0.33 _+ 0.07, 0.47 + 
0.29, 0.48 _ 0.16 ng/ml for functional classes I, II and III, 
respectively (p = 0.40; normal* 0.25 + 0.15 ng/ml); hANP: 
48 +_ 24, 54 _+ 22, 75 _+ 40 pg/ml for functional classes I, II 
and III, respectively (p -- 0.30; normal* 31 _+ 15 pg/ml). 
Myocardial uptake and washout of MIBG. The heart/ 
mediastinal ctivity ratio in the immediate images (Fig. 1, top) 
did not show any significant differences between the patient 
and control groups. The myocardial washout of MIBG (Fig. 1, 
bottom) was increased in proportion to the severity of heart 
failure. 
Myocardial washout of MIBG versus neuroendocrine mea- 
surements. Myocardial washout ended to correlate positively 
with neuroendocrine levels, but the association was not statis- 
tically significant (myocardial washout vs. norepinephrine, p = 
0.28; vs. hANP, p = 0.07). 
Myocardial washout of MIBG versus echocardiographic 
measurements. Myocardial washout correlated positively with 
left atrial diameter (r --- 0.51, p = 0.02) and correlated 
*Normal range for Japanese adults (18). 
inversely with mitral valve area obtained by Doppler study (r = 
-0.61, p < 0.01). 
Myocardial washout of MIBG versus hemodynamic mea- 
surements. Myocardial washout did not correlate significantly 
with right atrial pressure (p = 0.22), pulmonary capillary 
wedge pressure (p = 0.17), mean pulmonary artery pressure 
(p = 0.64) or mean aortic pressure (p = 0.14). However, it 
correlated inversely with mitral valve area calculated with the 
Gorlin equation (r = -0.62, p = 0.02; Fig. 2, top). The closest 
correlation existed between cardiac index (r = -0.80, p < 0.01; 
Fig. 2, bottom). 
Among various neuroendocrine, hemodynamic and echo- 
cardiographic variables, only cardiac index was found to be an 
independent and significant predictor of myocardial washout 
of MIBG (Myocardial washout = 90.7 -19.6 × Cardiac index, 
r = 0.80, p < 0.01). 
Accumulation and washout of MIBG in the liver. The 
liver/mediastinal ctivity ratio in immediate image was 2.91 _+ 
0.52 and washout of MIBG in the liver was 32 _+ 15% in the 
control group. Accumulation and washout of MIBG in the 
liver did not show any significant differences in any functional 
class of the patient or control group. 
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Discuss ion 
The major finding of this study is that in patients with heart 
failure due to mitral stenosis, myocardial washout of 1-123 
MIBG was accelerated corresponding to the severity of heart 
failure. MIBG imaging results for the liver were similar in the 
patient and control groups. This evidence suggests hat even in 
patients with heart failure without left ventricular volume or 
pressure overload, myocardial washout of MIBG increases, 
reflecting the intensified myocardial drenergic nerve activity. 
This result corroborates our hypothesis that intensification of 
myocardial adrenergic activity exists in patients with heart 
failure independent of the underlying cause, which has been 
suggested (6) in patients with cardiomyopathy who have heart 
failure and patients with valve disease with volume or pressure 
overload, or both (6). 
The myocardial uptake of MIBG at low concentrations, 
used in clinical applications, represents mainly neuronal up- 
take (5,19,20). MIBG is also taken up by the liver, which does 
not have dense adrenergic innervation (21). In the present 
study, MIBG images of the liver were similar in the patient and 
control groups. Therefore, the abnormal myocardial MIBG 
imaging results observed in our study were assumed to be 
related specifically to adrenergic nervous activity in the heart. 
We excluded patients with mitral stenosis and right heart 
failure or myocardial dysfunction from our patient group. 
Thus, the abnormal MIBG imaging observed was presumably 
related to left heart failure due to mechanical abnormality 
associated with mitral stenosis. 
Myocardial uptake of MIBG. In the immediate images, the 
heart/mediastinal activity ratio in the patient and control 
groups did not differ. Our data agreed with studies (6,22) 
showing that initial MIBG uptake is normal in valve disease. It 
has been demonstrated (6) that the uptake ability of norepi- 
nephrine is reduced in severe heart failure produced by 
cardiomyopathy because of the myocardial injury. In the 
present study, myocardial function in our patient group was 
presumably preserved. The lack of myocardial dysfunction may 
be the reason for the normal heart/mediastinal activity ratio, 
which reflects normal uptake ability of norepinephrine. 
Myocardial washout of MIBG. In the present study, myo- 
cardial washout of MIBG was accelerated in proportion to the 
severity of heart failure. Acceleration of washout was not 
observed in the liver; thus, the change was not general, but 
specific to the heart. Abnormal findings on myocardial MIBG 
images have been demonstrated in various diseases. Acceler- 
ation of washout has been reported (23) in patients with 
chronic renal failure, but our study patients had normal renal 
function (data not shown). In patients with pheochromocy- 
toma (24), the myocardial MIBG accumulation was inversely 
related to plasma catecholamines. It is possible that an in- 
crease in norepinephrine could compete with MIBG at the 
receptor site and thus influence the MIBG images. However, 
the plasma norepinephrine levels in our study were lower than 
those in their study, and plasma norepinephrine did not 
correlate with myocardial washout of MIBG in our patients. 
Therefore, the acceleration of washout in our study was 
primarily attributable toheart failure. 
Accelerated washout has been also reported (4,6) in pa- 
tients with cardiomyopathy and in those with valve disease. But 
it is not clear whether accelerated washout occurs in neuronal 
or extraneuronal sites. In a heart failure model of cardiomyo- 
pathic Syrian hamsters (25), accelerated MIBG washout was 
observed and the neuronal and nonneuronal components were 
evaluated by pretreatment with desipramine. In that study, 
accelerated washout was mainly due to increased release from 
the neuronal component, and the facilitated exocytotic release 
due to increased firing of the sympathetic nerves accounted for 
the accelerated washout of MIBG. There is a species pecific- 
ity, and we can not extrapolate these results to our study 
directly, but the extraneuronal myocardial uptake of MIBG in 
humans has been reported to be less than that in hamsters. 
Therefore, on the basis of findings obtained from that exper- 
imental study, we consider that the accelerated washout of 
MIBG in our study may reflect an increased presynaptic 
norepinephrine release, mainly due to the facilitated exocytotic 
release caused by increased firing of the sympathetic nerves. 
The present data showed a significant correlation between 
myocardial washout and left atrial diameter, mitral valve area 
and cardiac index. Mean right atrial pressure, pulmonary 
capillary wedge pressure and mean aortic pressure tended to 
correlate positively but not significantly. Among the variables 
examined, only cardiac index was an independent and signifi- 
cant predictor of myocardial washout of MIBG. These findings 
are of interest in relation to the mechanism ofadrenergic nerve 
activation in patients with mitral stenosis. Autonomic ontrol 
of the heart is regulated by afferent neural mechanisms that 
interact with the medullary cardiovascular centers. An inhibi- 
tory influence on adrenergic efferent outflow is exerted by 
activation of arterial and cardiopulmonary baroreceptors (26). 
In patients with low output heart failure, an activation of the 
adrenergic nerve system resulting from an attenuation of 
arterial baroreflex afferent activity is elicited (27). In patients 
with mitral stenosis, low output associated with mitral stenosis 
is a major factor determining the severity of left heart failure. 
Thus, the close correlation between myocardial washout and 
cardiac index suggests that low output is a potent stimulant of 
adrenergic nerve activity in patients with mitral stenosis. 
Plasma norepinephrine and hANP. Concentrations of 
plasma hANP and norepinephrine t nded to correlate posi- 
tively but not significantly with myocardial washout. We found 
a positive correlation between myocardial washout and hANP 
in patients with heart failure produced by cardiomyopathy and 
valve diseases with volume or pressure overload, or both, 
which independently represent the severity of heart failure. It 
has been reported (28) that elevation of atrial pressure in- 
creases the secretion of hANP. The present study patients had 
a high pulmonary capillary wedge pressure reflecting elevated 
atrial pressure caused by mitral stenosis, which may in turn 
activate hANP secretion independent of the severity of heart 
failure. In our patients, cardiac index, but not pulmonary 
capillary wedge pressure, was a potent factor in determining 
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myocardial washout. Therefore, in patients with heart failure 
due to mitral stenosis, hANP levels did not correlate with 
myocardial washout of MIBG. 
In patients with heart failure, plasma norepinephrine levels 
reflect overall systemic adrenergic activity; thus, MIBG imag- 
ing is a more accurate way of evaluating myocardial adrenergic 
activity (6). The present data indicate that in patients with 
mitral stenosis, it is possible to evaluate myocardial adrenergic 
nerve activity more accurately by using MIBG imaging than by 
using measurements of plasma norepinephrine concentration. 
Conclusions. The present results are the first to suggest he 
existence of intensified adrenergic nerve activity in patients 
with heart failure without volume or pressure overload. A 
decrease in cardiac output acts as a potent stimulus for this 
intensification. It is suggested that in patients with heart failure 
of any underlying cause, intensified myocardial adrenergic 
nerve activity should be considered a contributing factor. 
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